Valbenazine Completed Phase 4 Trials for Tardive Dyskinesia (TD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03698331
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
NCT03891862
Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia